Retraction Notice: Design and Docking Studies of [Diethylenetriaminepentaacetic Acid—(Amino Acid) 2 ] with Acetylcholine Receptor as a Molecular Imaging Agent for Single-Photon Emission Computed Tomographic Application (Molecular Imaging, (2012), 11, 3, (7290.2011.00044), 10.2310/7290.2011.00044);Design and docking studies of [diethylenetriaminepentaacetic acid-(amino acid)2] with acetylcholine receptor as a molecular imaging agent for single-photon emission computed tomographic application

Molecular Imaging

Volumn 11, Issue 3, 2012, Pages 240-250

  Tiwari, Anjani K ^a,b   Rathore, Vikas Singh ^a,b   Sinha, Deepa ^a,b   Datta, Anupama ^a,b   Sehgal, Neeta ^a,b   Chuttani, Krishna ^a,b   Mishra, Anil K ^a,b  

^a INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FREE ENERGY; MOLECULAR IMAGING; PARTICLE BEAMS; RADIOACTIVE TRACERS; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

ACETYLCHOLINE RECEPTOR; ACTIVE SITE; AMINO-ACIDS; COMPUTED TOMOGRAPHIC; DESIGN STUDIES; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DOCKING STUDIES; EMISSION COMPUTED; IMAGING AGENT; SINGLE PHOTON EMISSION;

AMINO ACIDS;

AMINO ACID; CHOLINERGIC RECEPTOR; PENTETIC ACID;

ANIMAL; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; METHODOLOGY; MOUSE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AMINO ACIDS; ANIMALS; MICE; MODELS, MOLECULAR; PENTETIC ACID; RECEPTORS, CHOLINERGIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84862702362     PISSN: 15353508     EISSN: 15360121     Source Type: Journal    
DOI: 10.1177/15353508241261163     Document Type: Erratum

References (28)

1. Ferro-Flores G, Arteaga de Murphy C, Meléndez-Alafort L. Third generation radiopharmaceuticals for imaging and targeted therapy. Curr Pharm Analysis 2006;2:339-52, doi:10.2174/15734120677 8699555. (Pubitemid 44697214)
2. Horn RK, Kutzeenellenbogen JA. Technetium-99m-labeled receptor-specific small-molecule radiopharmaceuticals: recent developments and encouraging results. Nucl Med Biol 1997;24:485-98, doi:10.1016/S0969-8051 (97) 00066-8.
3. Denoyer D, Perek N, Le Jeune N, Dubois F. Spectrum of radiopharmaceuticals in nuclear oncology. Curr Cancer Drug Targets 2006;6:181-96, doi:10.2174/156800906776842984. (Pubitemid 43764739)
4. Laverman P, Boerman OC, Corstens FH, Oyen WJ. Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 2002;29:681-90, doi:10.1007/s00259-002-0856-8. (Pubitemid 34591703)
5. Kubota K, Yamada K, Fukada H, et al. Tumor detection with carbon-11-labelled amino acids. Eur J Nucl Med 1984;9:136-40, doi:10.1007/BF00253516. (Pubitemid 14173032)
6. Wester HJ, Herz M, Weber W, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 1999;40:205-12. (Pubitemid 29044193)
7. Johnstone RM, Scholefield PG. Amino acids transport in tumor cells. Cancer Res 1965;9:143-226, doi:10.1016/S0065-230X (08) 60447-9.
8. Bush H, Davis JR, Honing GR, et al. The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues. Cancer Res 1959;19:1030-9.
9. Miyagawa T, Oku T, Uehara H, et al. facilitated amino acid transport is unregulated in brain tumors. J Cereb Blood Flow Metab 1998;18:500-9, doi:10.1097/00004647-199805000-00005. (Pubitemid 28213534)
10. Isselbacher KJ. Sugar and amino acid transport by cells in culture: differences between normal and malignant cells. N Engl J Med 1972;286:929-33, doi:10.1056/NEJM197201062860111.
11. Souba WW. Glutamine and cancer. Ann Surg 1993;218:715-28, doi:10.1097/00000658-199312000-00004. (Pubitemid 24005815)
12. Souba WW, Pacitti AJ. How amino acids get into cells: mechanisms, models, menus and mediators. JPEN J Parenter Enteral Nutr 1992;16:569-78, doi:10.1177/0148607192016006569.
13. Christensen HN. Role of amino acid transport and counter transport in nutrition and metabolism. Physiol Rev 1990;70:43-77. (Pubitemid 20037281)
14. Oxender DL, Christensen HN. Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 1963;238:3686-99.
15. Shotwell A, Jayme DW, Killberg M, Oxender DL. Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 1981;256:5422-7. (Pubitemid 11035379)
16. Jager PL, Vaalburg W, Pruim J, et al. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-45. (Pubitemid 32207394)
17. Langen KJ, Jarosch M, Muhlensiepen H, et al. Comparison of fluorotyrosines and methionine uptake in F98 rat gliomas. Nucl Med Biol 2003;30:501-8, doi:10.1016/S0969-8051 (03) 00023-4. (Pubitemid 36776519)
18. Zhang D-W, Yang Z-Y, Wang B-D, et al. Synthesis neutral rare earth complexes of diethylenetriamine-N, N-bis (acetyl-isoniazid) - N, N-, N-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging. Chem Pharm Bull 2006;54:1203-6, doi:10.1248/cpb.54.1203. (Pubitemid 44166418)
19. Fu Y, Laurent S, Muller RN. Synthesis of a sialyl Lewis mimetic conjugated with DTPA, potential ligand of new contrast agents for medical imaging. Eur J Org Chem 2002. 3966-73.
20. Liu S, Edwards DS. Synthesis and characterization of two (111) Inlabeled DTPA-peptide conjugates. Bioconj Chem 2001;12:630-4. (Pubitemid 32696238)
21. Liu M, Xu W, Xu L-J, et al. Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: a new folate-derived, (99m) Tc-based radiopharmaceutical. Bioconjug Chem 2005;16:1126-32. (Pubitemid 41368114)
22. Chen Y, Huang ZW, He L, et al. Synthesis and evaluation of a technetium-99m-labeled diethylenetriaminepentaacetate-deoxyglucose complex ([99mTc]-DTPA-DG) as a potential imaging modality for tumors. Appl Radiat Isot 2006;64:342-7, doi:10.1016/j.apradiso.2005.08.004. (Pubitemid 41803063)
23. Chen X, Li L, Liu F, Liu B. Synthesis and biological evaluation of technetium-99m-labeled deoxyglucose derivatives as imaging agents for tumor. Bioorg Med Chem Lett 2006;16:5503-6, doi:10.1016/j.bmcl.2006.08.050. (Pubitemid 44415465)
24. Tiwari AK, Sinha D, Datta A, et al. Kinetics of formation for lanthanide (III) complexes of DTPA-(Me-Trp) 2 used as imaging agent. Chem Biol Drug Des 2011;77:388-92, doi:10.1111/j.1747-0285.2011.01103.x.
25. Sinha D, Shukla G, Tiwari AK, et al. 99mTc-DTPA-amino acids conjugate as specific SPECT pharmaceuticals for tumour imaging. Chem Biol Drug Des 2009;74:159-64, doi:10.1111/j.1747-0285. 2009.00839.x.
26. Kakkar D, Tiwari AK, Chuttani K, et al. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: tecnetium-99mglutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis (glutamate) conjugate for tumor imaging. Cancer Biother Radiopharm 2010;25:645-55, doi:10.1089/cbr.2010. 0848.
27. Sinha D, Shukla G, Chuttani H, et al. Synthesis and biological evaluation of 99mTcDTPA-bis (His) as a potential probe for tumor imaging with SPECT. Cancer Biother Radiopharm 2009;24:615-20.
28. Singh S, Ojha H, Tiwari AK, et al. Design synthesis and in-vitro anti-proliferative activity of beazimidazole analogues for radiopharmaceutical efficacy. Cancer Biother Radiopharm 2010;25:245-50.